VanEck Associates’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,980
Closed -$66K 1439
2026
Q1
$66K Sell
1,980
-314
-14% -$13.1K ﹤0.01% 1324
2025
Q4
$104K Buy
2,294
+984
+75% +$36K ﹤0.01% 1322
2025
Q3
$40K Buy
1,310
+254
+24% +$7.81K ﹤0.01% 1350
2025
Q2
$31K Hold
1,056
﹤0.01% 1340
2025
Q1
$37K Buy
1,056
+71
+7% +$2.81K ﹤0.01% 1313
2024
Q4
$44K Buy
985
+315
+47% +$14.1K ﹤0.01% 1300
2024
Q3
$27K Sell
670
-379
-36% -$14.3K ﹤0.01% 1304
2024
Q2
$28K Hold
1,049
﹤0.01% 1315
2024
Q1
$31K Buy
1,049
+105
+11% +$3.18K ﹤0.01% 1302
2023
Q4
$36K Buy
944
+156
+20% +$5.74K ﹤0.01% 1306
2023
Q3
$35K Hold
788
﹤0.01% 1306
2023
Q2
$58K Sell
788
-48
-6% -$3.24K ﹤0.01% 1296
2023
Q1
$49K Sell
836
-19
-2% -$1.05K ﹤0.01% 1308
2022
Q4
$43K Buy
855
+296
+53% +$17.8K ﹤0.01% 1326
2022
Q3
$49K Buy
+559
New +$58.7K ﹤0.01% 1266

Other funds holding OMCL

VanEck Associates's OMCL Position: Q2 2026 in Review

VanEck Associates sold out of Omnicell (OMCL) in Q2 2026, closing a stake of 1,980 shares — an estimated $66K sold.

VanEck Associates first reported a position in OMCL in Q3 2022 and held it in 15 quarters. The position peaked at $104K in Q4 2025. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • VanEck Associates reported no remaining Omnicell position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 1,980 Omnicell shares in Q2 2026, an estimated $66K.
  • VanEck Associates first reported a position in Omnicell in Q3 2022 and held it in 15 quarters.
  • VanEck Associates's Omnicell position peaked at $104K in Q4 2025.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.